The Intranasal Drug Delivery Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Intranasal Drug Delivery Devices Market?
The market for intranasal drug delivery devices has seen robust expansion in past years. The market size rose from $60.27 billion in 2024 to $65.59 billion in 2025, boasting a compound annual growth rate (CAGR) of 8.8%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Intranasal Drug Delivery Devices Industry?
The Intranasal Drug Delivery Devices Global Market is projected to reach a value of $92.05 billion in 2029, with a compound annual growth rate (CAGR) of 8.8%.
Download Your Free Sample of the 2025 Intranasal Drug Delivery Devices Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Intranasal Drug Delivery Devices Market?
The key drivers in the intranasal drug delivery devices market are:
• The growth is tied to the rise in the global geriatric population
• It's fueled by increasing respiratory health issues worldwide
• The expanding applications in neurological disorders are driving the market
• Growth in preventative healthcare measures and personal medicine trends are key drivers.
Global Market Segmentation: Identifying Major Intranasal Drug Delivery Devices Industry Segments
The intranasal drug delivery devices market covered in this report is segmented –
1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products
2) By Dosage: Unit-Dose, Multi-Dose
3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications
4) By End User: Hospitals, Clinics, Homecare, Other End Users
Pre-order the 2025 Intranasal Drug Delivery Devices Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Intranasal Drug Delivery Devices Market?
The key trends in the intranasal drug delivery devices market are:
• Advances in formulation technologies are leading to novel devices for intranasal drug delivery.
• There is a growing focus on pediatric and geriatric applications, catering to these specific demographic needs.
• Self-administration devices are becoming more prevalent, empowering patients and reducing dependencies.
• Incorporation of biologics and peptides into intranasal drug delivery is an upcoming trend, enhancing drug effectiveness.
Who Are the Top Competitors & Leading Players in the Intranasal Drug Delivery Devices Market?
Major companies in the intranasal drug delivery devices market are:
• Johnson and Johnson Inc.
• Merck and Co.Inc.
• Novartis AG
• AstraZeneca plc.
• GlaxoSmithKline PLC
• 3M Company
• Becton, Dickinson and Company
• Teva Pharmaceutical Industries Ltd.
• AptarGroup Inc.
• West Pharmaceutical Services Inc.
• Teleflex Incorporated
• Recipharm AB
• Nemera Development S.A.
• Consort Medical plc.
• Vectura Group PLC
• Douglas Pharmaceuticals Ltd.
• Avanir Pharmaceuticals
• OptiNoset Inc.
• Flamel Technologies
• Aegis Therapeutics LLC
• Sonoma Pharmaceuticals
• PendoPharm Inc.
• Kurve Technology Inc.
• Impel NeuroPharma
• Impexium Medical Products
• B.F. Ascher and Company Inc.
• ENT Technologies Pty. Ltd.
• Neurelis Inc.
• Generex Biotechnology Corporation
Regional Dominance: Which Area Leads the Global Intranasal Drug Delivery Devices Market?
North America was the largest region in the intranasal drug delivery devices market in 2024
